摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N,N-diethylterephthalamide

中文名称
——
中文别名
——
英文名称
N,N-diethylterephthalamide
英文别名
N1,N1-diethylterephthalamide;4-N,4-N-diethylbenzene-1,4-dicarboxamide
N,N-diethylterephthalamide化学式
CAS
——
化学式
C12H16N2O2
mdl
MFCD17641842
分子量
220.271
InChiKey
XDVBMAYPGCABDC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.1
  • 重原子数:
    16
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.333
  • 拓扑面积:
    63.4
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    4-cyano-N,N-diethylbenzamide双氧水potassium carbonate 作用下, 以 二甲基亚砜 为溶剂, 以67%的产率得到N,N-diethylterephthalamide
    参考文献:
    名称:
    通过烷基硼酸与伯酰胺的铜催化交叉偶联选择性形成仲酰胺
    摘要:
    首次展示了伯酰胺和烷基硼酸交叉偶联的通用催化程序。该反应成功的关键是确定了弱碱(NaOSiMe 3)和氧化剂(二叔丁基过氧化物)以促进铜催化反应的高产率。这种转化为酰胺的单烷基化提供了一种简便、高产的方法。
    DOI:
    10.1021/ol401004r
点击查看最新优质反应信息

文献信息

  • PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING
    申请人:GUNZNER Janet L.
    公开号:US20110092461A1
    公开(公告)日:2011-04-21
    The invention provides novel inhibitors of hedgehog signaling that are useful as a therapeutic agents for treating malignancies where the compounds have the general formula I: wherein A, X, Y R 1 , R 2 , R 3 , R 4 , m and n are as described herein.
    本发明提供了新型的刺猬信号抑制剂,可用作治疗恶性肿瘤的治疗剂,其中化合物具有一般式I:其中A、X、Y、R1、R2、R3、R4、m和n如本文所述。
  • PIPERAZINE COMPOUNDS FOR THE INHIBITION OF HAEMATOPOIETIC PROSTAGLANDIN D SYNTHASE
    申请人:Aicher Babette
    公开号:US20100234377A1
    公开(公告)日:2010-09-16
    The present invention relates to compounds of general formula (I): wherein A, Y, X, n and B are as defined herein; and their use in the treatment and prevention of metabolic disorders, inflammatory conditions, allergic conditions, fever, pain including allodynia and nociception, eating disorders, cachexia, brain injuries, cancer of the genitals, sleep apnea, cardiovascular disease, flush effect associated with nicotinic acid and related compounds or for the promotion of wound healing. Certain compounds of general formula (I) are new and the invention also relates to these compounds and to their use in medicine.
    本发明涉及一般式(I)的化合物:其中A、Y、X、n和B如此定义;以及它们在治疗和预防代谢紊乱、炎症病症、过敏症、发热、疼痛(包括触觉过敏和痛觉敏感)、进食障碍、消瘦症、脑损伤、生殖器癌症、睡眠呼吸暂停、心血管疾病、烟酸及相关化合物引起的潮红反应或促进伤口愈合方面的用途。某些一般式(I)的化合物是新的,本发明还涉及这些化合物及其在医学上的应用。
  • Direct magnesiation of organic materials
    申请人:ARCH DEVELOPMENT CORPORATION
    公开号:EP0418013A2
    公开(公告)日:1991-03-20
    A method for magnesiating a compound substituted with one or more activating groups beta (ortho) to a carbon atom having a hydrogen substituent to be deprotonated. The compound is either a saturated cyclic compound in which the carbon-carbon bonds are strained greater than the carbon-carbon bonds of cyclobutane, or an unsaturated compound in which the carbon atom to be deprotonated is located no more than one position away from a pi-bonded carbon atom. The method contacts the substituted compound with a reactant having the formula: wherein W is: and R₁, R₂, R₃ and R₄ independently include hydrogen, alkyl, aryl, alkylaryl, and heteroaryl, or R and R₂ and/or R₃ and R₄ together form a cyclic residue. Compounds substituted with one or more magnesium-­containing groups and one or more activating groups are also disclosed. The activated compounds are either saturated cyclic compounds having carbon-carbon bonds that are strained greater than the carbon-carbon bonds of cyclobutane, or unsaturated compounds. The one or more magnesium-containing groups have the structure: with R₁ and R₂ independently including hydrogen, alkyl, aryl, alkylaryl, and heteroaryl, or R₁ and R₂ together forming a cyclic residue. A method by which such compounds are reacted with electrophilic reagents replacing the magnesium containing groups with substituent groups is also disclosed.
    一种镁化化合物的方法,该化合物被一个或多个活化基团β(正交)取代,该基团与具有氢取代基的碳原子相连,该碳原子将被去质子化。该化合物可以是饱和环状化合物,其中碳-碳键的张力大于环丁烷的碳-碳键;也可以是不饱和化合物,其中需要去质子化的碳原子与π键碳原子的距离不超过一个位置。该方法将取代的化合物与具有以下式子的反应物接触: 其中 W 是 和 R₁、R₂、R₃ 和 R₄ 独立地包括氢、烷基、芳基、烷芳基和杂芳基,或 R 和 R₂ 和/或 R₃ 和 R₄ 共同形成环状残基。此外,还公开了被一个或多个含镁基团和一个或多个活化基团取代的化合物。活化化合物可以是饱和环状化合物,其碳-碳键的张力大于环丁烷的碳-碳键,也可以是不饱和化合物。一个或多个含镁基团的结构如下 R₁ 和 R₂ 独立地包括氢、烷基、芳基、烷芳基和杂芳基,或 R₁ 和 R₂ 共同形成环状残基。此外,还公开了一种方法,通过该方法,此类化合物可与亲电试剂反应,用取代基取代含镁基团。
  • Complexed hydroquinones
    申请人:POLAROID CORPORATION
    公开号:EP0523470A2
    公开(公告)日:1993-01-20
    Hydroquinones form stable hydrogen-bonded complexes with N,N,N',N'-tetrasubstituted diamides of aromatic dicarboxylic acids in which two carboxyl groups are arranged para to one another on the same phenyl ring. These complexes are useful in rendering the hydroquinones more water-dispersible to assist their incorporation into photographic products. Also, the diamides may be incorporated into photographic products to reduce or eliminate various problems associated with hydroquinones, including migration of hydroquinones within the product during storage and the discoloration of images on storage due to oxidation of hydroquinone present in an image-receiving element of the photographic product.
    对苯二酚与芳香族二羧酸的 N,N,N',N'-四取代二酰胺形成稳定的氢键络合物,其中的两个羧基在同一苯环上相互对位排列。这些络合物可以使对苯二酚更容易在水中分散,从而有助于将其加入到感光产品中。此外,二酰胺还可以加入到感光产品中,以减少或消除与对苯二酚有关的各种问题,包括对苯二酚在储存过程中在产品内部的迁移,以及由于感光产品的图像接收元件中存在的对苯二酚氧化而导致图像在储存过程中变色。
  • N<sub>2</sub> Extrusion and CO Insertion: A Novel Palladium-Catalyzed Carbonylative Transformation of Aryltriazenes
    作者:Wanfang Li、Xiao-Feng Wu
    DOI:10.1021/acs.orglett.5b00603
    日期:2015.4.17
    A novel procedure for the replacement of N-2 with CO of aryltriazenes has been developed. Aryltriazenes were converted to the corresponding arylamides catalyzed by 1 mol % of PdCl2/P(o-Tol)(3) under CO pressure. In this process, aryldiazonium salts were generated in the presence of 40 mol % of MeSO3H. Nitrogen was released from the substrates and CO formally inserted. Aryl bromides, iodides, alkynes, and free hydroxyl groups can be tolerated in this transformation.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐